Valuation

HCAHCA Healthcare

StockNYSEAmerika Birleşik DevletleriHealth careEU retail: available
—/10

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricHCASector medianvs median
P/E15,428,8 · n=114%47 below
P/B—3,0 · n=196—
P/S1,43,7 · n=202%63 below
EV/EBIT—24,1 · n=103—
Free-cash-flow yield%7,6%2,8 · n=187%171 above
Dividend yield%0,65%0,00 · n=215—
Return on equity—%2,7 · n=193—
Return on invested capital—%3,5 · n=176—
Gross margin—%62,5 · n=152—
Net debt / EBITDA—1,19 · n=108—

Value factor: 70 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

InstrumentP/EP/BEV/EBITFree-cash-flow yieldDividend yieldSmart Score
LLYEli Lilly & Co42,633,6—%1,6%0,66/10
JNJJohnson & Johnson29,17,2—%3,6%2,18/10
ABBVAbbVie79,9—33,5%3,6%3,05/10
MRKMerck114,68,7—%4,4%2,38/10
UNHUnitedHealth25,13,418,6%6,7%2,39/10
TMOThermo Fisher Scientific35,74,735,2%2,9%0,38/10
AMGNAmgen26,319,724,0%4,4%2,36/10
GILDGILEAD—16,1—%6,8%2,14/10
ABTAbbott28,53,426,8%4,1%3,05/10
PFEPfizer38,42,0—%6,6%5,91/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 Mar 2026 · filed 29 Nis 2026